Significance of Metabolite Ratios in the Interpretation of Segmental Hair Testing Results—Differentiation of Single from Chronic Morphine Use in a Case Series
Abstract
:1. Introduction
1.1. Background
1.2. Case Series
1.2.1. Case 1: Non-Fatal Morphine Intoxication
1.2.2. Case 2: Fatal Morphine Intoxication
1.2.3. Case 3: Fatal Morphine Intoxication
1.2.4. Case 4: Fatal Morphine Intoxication
1.2.5. Therapeutic, Chronic Morphine Use
2. Results
2.1. Morphine Intoxication Cases
2.2. Documented Chronic Morphine Use
3. Discussion
4. Materials and Methods
4.1. Collection and Analysis of Blood and Urine Samples in the Intoxication Cases
4.2. Hair Sample Collection and Analysis
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Morgan, M.M.; Christie, M.J. Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human. Br. J. Pharmacol. 2011, 164, 1322–1334. [Google Scholar] [CrossRef] [Green Version]
- Kintz, P. Value of hair analysis in postmortem toxicology. Forensic Sci. Int. 2004, 142, 127–134. [Google Scholar] [CrossRef]
- Pragst, F.; Balíková, M. State of the art in hair analysis for detection of drug and alcohol abuse. Clin. Chim. Acta 2006, 370, 17–49. [Google Scholar] [CrossRef]
- Henderson, G. Mechanisms of drug incorporation into hair. Forensic Sci. Int. 1993, 63, 19–29. [Google Scholar] [CrossRef]
- Harkey, M. Anatomy and physiology of hair. Forensic Sci. Int. 1993, 63, 9–18. [Google Scholar] [CrossRef]
- Cooper, G.A.; Kronstrand, R.; Kintz, P. Society of Hair Testing guidelines for drug testing in hair. Forensic Sci. Int. 2012, 218, 20–24. [Google Scholar] [CrossRef]
- Callaghan, R.R.; Wilson, J.F.; Cartwright, J. An Assessment of the Routes of Incorporation of Opiates into Beard Hair After a Single Oral Dose of Codeine. Ther. Drug Monit. 1996, 18, 724–728. [Google Scholar] [CrossRef] [PubMed]
- Yegles, M.; Wennig, R. Incorporation of propyphenazone in beard hair of a migraine patient. Forensic Sci. Int. 2000, 107, 233–237. [Google Scholar] [CrossRef]
- Moosmann, B.; Roth, N.; Auwärter, V. Finding cannabinoids in hair does not prove cannabis consumption. Sci. Rep. 2015, 5, 14906. [Google Scholar] [CrossRef] [Green Version]
- Cone, E.J. Testing Human Hair for Drugs of Abuse. I. Individual Dose and Time Profiles of Morphine and Codeine in Plasma, Saliva, Urine, and Beard Compared to Drug-Induced Effects on Pupils and Behavior. J. Anal. Toxicol. 1990, 14, 1–7. [Google Scholar] [CrossRef]
- Cheshire, W.P.; Fealey, R.D. Drug-induced hyperhidrosis and hypohidrosis—Incidence, prevention and management. Drug Safety 2008, 31, 109–126. [Google Scholar] [CrossRef]
- Wang, X.; Johansen, S.S.; Nielsen, M.K.K.; Linnet, K. Segmental Hair Analysis—Interpretation of the Time of Drug Intake in Two Patients Undergoing Drug Treatment. J. Forensic Sci. 2019, 64, 950–955. [Google Scholar] [CrossRef] [PubMed]
- Kintz, P. Segmental hair analysis can demonstrate external contamination in postmortem cases. Forensic Sci. Int. 2012, 215, 73–76. [Google Scholar] [CrossRef] [PubMed]
- Kintz, P. Positive multi-sectional hair analysis does not mean repetitive administration of morphine. Toxicol. Anal. Clin. 2016, 28, 184–186. [Google Scholar] [CrossRef]
- Scholz, C.; Quednow, B.B.; Herdener, M.; Kraemer, T.; Baumgartner, M.R. Cocaine Hydroxy Metabolites in Hair: Indicators for Cocaine Use Versus External Contamination. J. Anal. Toxicol. 2019, 43, 543–552. [Google Scholar] [CrossRef]
- Madry, M.M.; Rust, K.Y.; Guglielmello, R.; Baumgartner, M.R.; Kraemer, T. Metabolite to parent drug concentration ratios in hair for the differentiation of tramadol intake from external contamination and passive exposure. Forensic Sci. Int. 2012, 223, 330–334. [Google Scholar] [CrossRef] [PubMed]
- Madry, M.M.; Bosshard, M.M.; Kraemer, T.; Baumgartner, M.R. Hair analysis for opiates: Hydromorphone and hydrocodone as indicators of heroin use. Bioanalysis 2016, 8, 953–964. [Google Scholar] [CrossRef]
- Beck, T.; Bruggmann, P.; Haemmig, R.; Caflisch, C.; Falcato, L.; Fink, A. Medizinische Empfehlungen für Opioidagonistentherapie (OAT) bei Opioidabhängigkeits-Syndrom 2020; SSAM: Bern, Switzerland, 2020. [Google Scholar]
- Wang, X.; Johansen, S.S.; Nielsen, M.; Linnet, K. Hair analysis in toxicological investigation of drug-facilitated crimes in Denmark over a 8-year period. Forensic Sci. Int. 2018, 285, e1–e12. [Google Scholar] [CrossRef] [PubMed]
- Madry, M.M.; Kraemer, T.; Baumgartner, M.R. Systematic assessment of different solvents for the extraction of drugs of abuse and pharmaceuticals from an authentic hair pool. Forensic Sci. Int. 2018, 282, 137–143. [Google Scholar] [CrossRef]
- De Giovanni, N.; Fucci, N. The Current Status of Sweat Testing For Drugs of Abuse: A Review. Curr. Med. Chem. 2013, 20, 545–561. [Google Scholar] [CrossRef]
- Tsanaclis, L.; Wicks, J.F. Differentiation between drug use and environmental contamination when testing for drugs in hair. Forensic Sci. Int. 2008, 176, 19–22. [Google Scholar] [CrossRef]
- Erne, R.; Bernard, L.; Steuer, A.E.; Baumgartner, M.R.; Kraemer, T. Hair Analysis: Contamination versus Incorporation from the Circulatory System-Investigations on Single Hair Samples Using Time-of-Flight Secondary Ion Mass Spectrometry and Matrix-Assisted Laser Desorption/lonization Mass Spectrometry. Anal. Chem. 2019, 91, 4132–4139. [Google Scholar] [CrossRef]
- Johansen, S.S.; Le Dang, L.T.V.; Nielsen, M.K.K.; Haage, P.; Kugelberg, F.C.; Kronstrand, R. Temporal patterns of tramadol in hair after a single dose. Forensic Sci. Int. 2020, 316, 110546. [Google Scholar] [CrossRef]
- Poetzsch, M.; Baumgartner, M.R.; Steuer, A.E.; Kraemer, T. Segmental hair analysis for differentiation of ti-lidine intake from external contamination using LC-ESI-MS/MS and MALDI-MS/MS imaging. Drug Test Anal. 2015, 7, 143–149. [Google Scholar] [CrossRef] [PubMed]
- Steuer, A.E.; Eisenbeiss, L.; Kraemer, T. Blood alcohol analysis alone versus comprehensive toxicological analysis—System-atic investigation of missed co-ingested other drugs in suspected alcohol-impaired drivers. Forensic Sci. Int. 2016, 267, 52–59. [Google Scholar] [CrossRef] [PubMed]
- Maurer, H.H. Maurer/Wissenbach/Weber LC-MSn Library of Drugs, Poisons, and Their Metabolites; Wiley-VCH: Weinheim, Germany, 2014. [Google Scholar]
- Steuer, A.E.; Forss, A.-M.; Dally, A.M.; Kraemer, T. Method development and validation for simultaneous quantification of 15 drugs of abuse and prescription drugs and 7 of their metabolites in whole blood relevant in the context of driving under the influence of drugs––Usefulness of multi-analyte calibration. Forensic Sci. Int. 2014, 244, 92–101. [Google Scholar] [CrossRef] [PubMed]
- Scholz, C.; Cabalzar, J.; Kraemer, T.; Baumgartner, M.R. A Comprehensive Multi-Analyte Method for Hair Analysis: Substance-Specific Quantification Ranges and Tool for Task-Oriented Data Evaluation. J. Anal. Toxicol. 2021, 45, 701–712. [Google Scholar] [CrossRef]
Case no. | Type | Sex | Age at Incident | Mor Dose | Hair Color | Total Tested Hair Length (cm) | Free Mor Conc. in Venous Blood (micro G/L) | Free HyMor Conc. in Venous Blood (micro G/L) | Urine LCMS/MS Screening *) |
---|---|---|---|---|---|---|---|---|---|
1 | non-fatal | F | 100 | Unknown, most probably oral | White | 1st and 2nd sample:5 | 180 | nd | Mor + HyMor - |
2 | fatal | F | 16 | Unknown, most probably oral | Dark brown | 8 | 740 | nd | Mor + HyMor - |
3 | fatal | F | 76 | 50 and 5 mg, subcutaneous | Gray-dark brown- | 7 | 190 | nd | Mor + HyMor - |
4 | fatal | F | 92 | 5 mg twice, subcutaneous | White, few gray | 10.5 | 260 | nd | Mor + HyMor - |
Hair Analysis | Mor Conc. (pg/mg) | HyMor Conc. (pg/mg) | HyMor/Mor Conc. Ratios | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Case 1 (1st sample: 1 + 1 + 1 + 1 + 1 cm) **) | 44 | 34 | 29 | 27 | 29 | 3.3 | 2.1 | 1.7 | 1.5 | 1.4 | 0.075 | 0.062 | 0.059 | 0.056 | 0.048 | |
Case 1 (2nd sample: 1 + 1 + 1 + 1 + 1 cm) **) | 44 | 31 | 38 | 42 | 56 | 9.8 | 2.2 | 2.2 | 2.7 | 3.4 | 0.223 | 0.071 | 0.058 | 0.064 | 0.061 | |
Case 2 (1 + 2 + 2 + 3 cm) | 18 | 20 | 34 | 48 | – | ~1.6 | ~1.3 | 2.0 | 2.3 | – | 0.089 | 0.065 | 0.059 | 0.048 | ||
Case 3 (2 + 2 + 3 cm) | 3.3 | 3.6 | 4.8 | – | – | nd | nd | nd | – | – | ||||||
Case 4 (2 + 2 + 3 + 3.5 cm) | nd | nd | nd | nd | – | nd | nd | nd | nd | – |
Analysis of Initial Hair Wash Solution | Mor Conc. (pg/mg) | HyMor Conc. (pg/mg) | Wash/Hair Conc. Ratios for Mor | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Case 1 (1st sample: 1 + 1 + 1 + 1 + 1 cm) **) | 22 | 25 | 22 | 20 | 17 | nd | 0.50 | 0.74 | 0.76 | 0.74 | 0.59 | |||||
Case 1 (2nd sample: 1 + 1 + 1 + 1 + 1 cm) **) | 6.9 | 6.5 | 8.4 | 9.7 | 11 | nd | 0.16 | 0.21 | 0.22 | 0.23 | 0.19 | |||||
Case 2 (1 + 2 + 2 + 3 cm) | 48 | 60 | 120 | 120 | – | nd | nd | nd | nd | – | 2.7 | 3.0 | 3.5 | 2.5 | ||
Case 3 (2 + 2 + 3 cm) | 3.5 | 4.6 | 8.8 | – | – | nd | nd | nd | – | – | 1.1 | 1.3 | 1.8 | |||
Case 4 (2 + 2 + 3 + 3.5 cm) | 5.2 | 4.3 | 5.3 | 10 | – | nd | nd | nd | nd | – |
Sample No. | Sex | Age | Daily Mor Dose (mg) | Hair Color | Total Tested Hair Length (cm) | Mean Mor Conc. of 1-cm Hair Segments (pg/mg) | Mean HyMor Conc. of 1-cm Hair Segments (pg/mg) | Mean HyMor/Mor Ratio of 1-cm Hair Segments | Mean Mor Wash/Hair Ratio of All 1-cm Hair Segments |
---|---|---|---|---|---|---|---|---|---|
1 | M | 50 | 320 | Dark brown-white | 5 | 5283 | 702 | 0.14 | 0.012 |
2 | M | 56 | 400 | Gray-white | 5 | 4800 | 1383 | 0.28 | 0.11 |
3 | M | 52 | 120 | Brown-gray | 5 | 2017 | 477 | 0.27 | 0.052 |
4 | M | 54 | 400 | Dark brown-gray | 5 | 9967 | 917 | 0.12 | 0.033 |
5 | M | 59 | 90 | Dark brown-gray | 4 | 1325 | 130 | 0.11 | 0.028 |
6 | M | 52 | 1200 | Brown-gray | 3 | 5750 | 1617 | 0.28 | 0.10 |
Hair Segment | Initial Hair Wash | Wash/Hair Ratio | Main Incorporation Pathway Indicating the Specified Mor Use | |||
---|---|---|---|---|---|---|
Mor (pg/mg) *) | HyMor | HyMor/Mor | Mor | HyMor | Mor | |
>200 | positive | >0.1 | positive | positive | <0.2 | via blood; regular, repeated/chronic Mor use |
<200 | positive | >0.1 | positive | positive | <0.2 | via blood; single/rare/occasional Mor use |
>200 | positive | <0.1 | positive | positive | >0.2 | via sweat/sebum and additionally via blood; potentially regular/chronic Mor use |
<200 | positive | <0.1 | positive | positive | >0.2 | via sweat/sebum; only very recent Mor use |
positive | nd | positive | positive or nd | >0.2 | via sweat/sebum; only very recent Mor use | |
nd | nd | positive | nd | via sweat/sebum; only very recent Mor use |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Madry, M.M.; Poetzsch, S.N.; Steuer, A.E.; Kraemer, T.; Baumgartner, M.R. Significance of Metabolite Ratios in the Interpretation of Segmental Hair Testing Results—Differentiation of Single from Chronic Morphine Use in a Case Series. Metabolites 2021, 11, 557. https://doi.org/10.3390/metabo11080557
Madry MM, Poetzsch SN, Steuer AE, Kraemer T, Baumgartner MR. Significance of Metabolite Ratios in the Interpretation of Segmental Hair Testing Results—Differentiation of Single from Chronic Morphine Use in a Case Series. Metabolites. 2021; 11(8):557. https://doi.org/10.3390/metabo11080557
Chicago/Turabian StyleMadry, Milena M., Sandra N. Poetzsch, Andrea E. Steuer, Thomas Kraemer, and Markus R. Baumgartner. 2021. "Significance of Metabolite Ratios in the Interpretation of Segmental Hair Testing Results—Differentiation of Single from Chronic Morphine Use in a Case Series" Metabolites 11, no. 8: 557. https://doi.org/10.3390/metabo11080557
APA StyleMadry, M. M., Poetzsch, S. N., Steuer, A. E., Kraemer, T., & Baumgartner, M. R. (2021). Significance of Metabolite Ratios in the Interpretation of Segmental Hair Testing Results—Differentiation of Single from Chronic Morphine Use in a Case Series. Metabolites, 11(8), 557. https://doi.org/10.3390/metabo11080557